Canadian Senate passes huge hike in fees to the industry
This article was originally published in Scrip
Executive Summary
The Canadian Senate adopted on 26 May proposals by Health Canada to allow it to increase user fees to pharmaceutical (and medical device) companies to cover its growing costs and workload delivering regulatory services. The proposals are expected to come into force in April 2011, officials have indicated.